TSX:PLI (PROMETIC LIFE SCIENCES INC)
About
Last updated Jun 15, 2021, 02:06:34pm EDTRelated Articles
These Were the Worst-Performing Stocks on the TSX Last Week
Will Ashworth | July 8, 2019
The S&P/TSX Composite Index finished the week of July 2-5 with an increase of 0.98%, a little more than half the S&P 500. Here... More »
These Growth Stocks Could Surge With a New NAFTA Deal
Kenrick Vassall | September 12, 2018
Pharmaceutical companies such as Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) could benefit from a new NAFTA deal that includes longer data protection for biologic drugs. More »
4 Stocks That Have Taken Off This Year!
David Jagielski | February 2, 2018
North American Palladium Ltd. (TSX:PDL) and these three other stocks have soundly outperformed the market in 2018, but will these impressive results continue? More »
5 Stocks That Are Already up More Than 25% in 2018
David Jagielski | January 8, 2018
Aurora Cannabis Inc. (TSX:ACB) is off to a hot start in 2018, but you probably won't be able to guess the other four stocks on... More »
Are These 3 Stocks About to Take Off?
David Jagielski | October 17, 2017
ProMetic Life Sciences Inc. (TSX:PLI) and these two other stocks have seen strong recoveries after dismal starts to 2017. More »
ProMetic Life Sciences Inc. Jumps More Than 21% on FDA Designation
Chris MacDonald | August 29, 2017
ProMetic Life Sciences Inc.'s (TSX:PLI) plasminogen drug Ryplazimä has been granted a "Rare Pediatric Disease" designation by the U.S. Food and Drug Administration, renewing investor... More »
Can You Double Your Money With ProMetic Life Sciences Inc.?
Joey Frenette | January 4, 2017
ProMetic Life Sciences Inc. (TSX:PLI) has a great pipeline of impressive drugs. Could this be your ticket to huge profits in 2017? More »
Is Now the Time to Buy ProMetic Life Sciences Inc.?
Chris MacDonald | December 22, 2016
ProMetic Life Sciences Inc. (TSX:PLI) is a biopharmaceutical company with lots of potential upside given its current pipeline of drugs. More »
What Is Inflaming ProMetic Life Sciences Inc.’s Latest Increase?
Scott Brandt | October 25, 2016
ProMetic Life Sciences Inc.'s (TSX:PLI) stock climbed by more than 10% this month after its diabetes drug reported 100% success in phase two clinical... More »
Why ProMetic Life Sciences Shares Soared
Brian Pacampara, CFA | March 27, 2014
Is this meaningful? Or just another movement? More »